CPWM LLC’s Regulus Therapeutics RGLS Stock Holding History

CPWM LLC’s Portfolio RGLS Stock Details RGLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-250	Closed	-$329K	–	280
2015 Q2	$329K	Buy	+250	New	+$403K	0.08%	152

Other funds holding RGLS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

CPWM LLC's RGLS Position: Q3 2015 in Review

CPWM LLC sold out of Regulus Therapeutics (RGLS) in Q3 2015, closing a stake of 250 shares — an estimated $329K sold.

CPWM LLC first reported a position in RGLS in Q2 2015 and held it in 1 quarter. The position peaked at $329K in Q2 2015. 92 funds tracked by Wall St. Rank hold RGLS as of Q3 2015.

CPWM LLC reported no remaining Regulus Therapeutics position as of Q3 2015 after selling out during the quarter.
CPWM LLC sold 250 Regulus Therapeutics shares in Q3 2015, an estimated $329K.
CPWM LLC first reported a position in Regulus Therapeutics in Q2 2015 and held it in 1 quarter.
CPWM LLC's Regulus Therapeutics position peaked at $329K in Q2 2015.
92 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q3 2015.

Based on CPWM LLC's 13F filing for Q3 2015, filed 9 Jun 2017.